The trajectory of Sildenafil presents a complex picture for those considering investment. While the initial introduction generated substantial profits, the expiration of its exclusive rights opened the avenue to generic alternatives, dramatically reducing market share. This creates a unique challenge for drug manufacturers depending on related bloc

The history of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, producing billions in income, its exclusivity period created a flood of lower-priced alternatives , significantly impacting its market share . While certain firms may attempt to capitalize on similar conditions , th